Log In
Print
BCIQ
Print
Print this Print this
 

BC-3781

  Manage Alerts
Collapse Summary General Information
Company Nabriva Therapeutics AG
DescriptionPleuromutilin antibiotic
Molecular Target
Mechanism of Action 
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today